Most vaccines are designed to provide immunity against just one pathogen. Vaccines for chicken pox (caused by varicella-zoster virus) were only developed to fight that one disease, for example. But in ...

Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.

COVID-19 vaccine boosters not only protect against SARS-CoV-2 – the virus behind the most recent pandemic – but may also help ...

The US Food and Drug Administration (FDA) has revised its guidance for developers of vaccines against COVID-19 as regulators and health authorities assess the need to adjust vaccines so they remain ...

2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...

Unlike traditional vaccines that target a single virus strain, pEVAC-PS uses a synthetic "super-antigen" created with the ...

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants ...

Healthcare workers (HCWs) played a critical role in the global response to the COVID-19 pandemic, providing essential ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

Covid-19 vaccine boosters may protect against some future coronaviruses that have yet to spread from animals to humans, ...